Solas OR Secures TGA Approval: A Milestone in Advancing Breast Cancer Surgeries in Australia
Cirdan’s state-of-the-art x-ray specimen system now approved for use in Australian healthcare facilities.
Cirdan, a leading global provider of laboratory information systems and diagnostic solutions, is pleased to announce that its cutting-edge x-ray specimen system, Solas OR, has received Therapeutic Goods Administration (TGA) approval for use within Australian healthcare facilities. This significant milestone marks an important step forward in advancing breast cancer surgeries, providing surgeons with a powerful tool to enhance precision and improve patient outcomes.
Significance Of TGA Approval
The Therapeutic Goods Administration (TGA) is Australia’s regulatory authority, ensuring that medical devices, medicines, and diagnostic tests meet strict safety, quality, and efficacy standards. Securing TGA approval is a rigorous process that verifies a product’s compliance with national healthcare regulations, confirming its safety and effectiveness for use in Australian healthcare settings.
Solas OR – The Future of Specimen Imaging
Solas OR is an innovative specimen radiography solution designed to deliver high-resolution imaging in real time during surgical procedures. Specifically optimised for breast cancer surgery, the system enables surgeons to verify the successful removal of abnormal tissue with greater accuracy, minimising the need for repeat surgeries and improving patient recovery times. Key features of Solas OR include:
· Rapid, High-Resolution Imaging: Utilizing photon-counting technology, Solas OR delivers exceptional imaging to assist surgeons with intraoperative decision-making.
· Enhanced Workflow Efficiency: A user-friendly interface designed to seamlessly integrate into the operating room, ensuring smooth and efficient procedures.
· Immediate Specimen Verification: Optimised for breast cancer surgeries, providing real-time feedback for surgeons to confirm tissue removal accuracy.
Cirdan’s Comprehensive Pathology Platform
Solas OR is a key component of Cirdan’s broader pathology platform, which offers a fully integrated, end-to-end diagnostic solution. The platform combines Laboratory Information Systems (LIS), digital pathology, and specimen imaging technologies into a unified workflow. This integration allows healthcare professionals to optimise efficiency, improve diagnostic accuracy, and enhance patient outcomes. By seamlessly linking data from imaging and pathology systems, Cirdan’s platform provides a comprehensive solution that improves clinical care and supports informed decision-making.
Supporting the Fight Against Breast Cancer
Breast cancer remains one of the most prevalent cancers globally, and in Australia, it accounts for approximately 28% of all new cancer diagnoses in women. One in seven women will face a breast cancer diagnosis in their lifetime (Breast Cancer Network Australia, 2024).
As part of Cirdan’s commitment to advancing the fight against cancer, the TGA approval of Solas OR is a significant step forward. By enabling greater surgical precision and reducing the need for repeat procedures, Solas OR will help improve patient outcomes and streamline breast cancer surgery. Cirdan is proud to offer this innovative solution to healthcare professionals, helping them deliver the highest standard of care to patients in Australia and beyond.
Looking Ahead
With the successful integration of Solas OR into Australian healthcare facilities, Cirdan is poised to make a lasting impact on breast cancer surgery. This approval marks just the beginning of the ongoing advancements in diagnostic medicine that Cirdan continues to champion. We look forward to the broader application of our platform and imaging technologies in breast cancer surgery and other critical areas of medical practice.
About Cirdan
Cirdan is a global leader in laboratory information systems and diagnostic solutions, dedicated to improving healthcare through innovation. With a comprehensive portfolio that includes cutting-edge specimen imaging technology, advanced data analytics, and integrated workflow solutions, Cirdan is committed to helping healthcare professionals improve patient outcomes and streamline clinical workflows.
For more information, please visit: www.cirdan.com
For media enquiries contact: Rebecca Fitton, Marketing Manager, Cirdan.
T: +44 (0) 28 9266 0880 E: rfitton@cirdan.com W: www.cirdan.com